BioMarin Pharmaceutical (NASDAQ:BMRN) introduced its longer-term outlook and plans to implement a $500M cost transformation program at its investor day event today. The California-based pharma has ...

Barinthus Biotherapeutics plc has announced its strategic transformation focusing on immunology and inflammatory diseases, highlighting its promising immunotherapy VTP-1000 for celiac disease, which ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

Digital transformation isn’t just about buying tools or upgrading software. It’s about how you run your business, how your people work, and how you solve problems. That’s where the real shift happens.

William Blair has initiated coverage on coverage of Bio-Techne Corp TECH with an Outperform rating. Bio-Techne is positioned in high-growth and attractive end-markets, notably cell and gene therapy (C ...

Emergent BioSolutions Inc. (NYSE:EBS) presented its fourth quarter and full year 2025 financial results on February 26, 2026, showcasing significant progress in its multi-year transformation plan even ...